ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $619,947 | -48.4% | 55,501 | -1.1% | 0.00% | – |
Q2 2023 | $1,200,454 | +52806.7% | 56,096 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $2,269 | -20.6% | 56,096 | -8.6% | 0.00% | 0.0% |
Q4 2022 | $2,856 | -99.9% | 61,380 | -12.9% | 0.00% | 0.0% |
Q3 2022 | $3,656,000 | +7.4% | 70,475 | -2.1% | 0.00% | 0.0% |
Q2 2022 | $3,404,000 | -64.8% | 72,018 | -50.5% | 0.00% | -66.7% |
Q1 2022 | $9,669,000 | +51.2% | 145,480 | +51.3% | 0.00% | +50.0% |
Q4 2021 | $6,395,000 | +34.2% | 96,158 | +17.9% | 0.00% | +100.0% |
Q3 2021 | $4,764,000 | +33.4% | 81,546 | +0.5% | 0.00% | 0.0% |
Q2 2021 | $3,572,000 | -14.8% | 81,156 | -4.5% | 0.00% | 0.0% |
Q1 2021 | $4,193,000 | +13.8% | 85,019 | -2.8% | 0.00% | 0.0% |
Q4 2020 | $3,683,000 | -11.2% | 87,473 | -3.4% | 0.00% | -50.0% |
Q3 2020 | $4,147,000 | -26.3% | 90,587 | -19.2% | 0.00% | 0.0% |
Q2 2020 | $5,629,000 | +10.7% | 112,114 | +13.4% | 0.00% | 0.0% |
Q1 2020 | $5,083,000 | -30.1% | 98,832 | -16.0% | 0.00% | -33.3% |
Q4 2019 | $7,268,000 | -42.3% | 117,651 | -43.9% | 0.00% | -40.0% |
Q3 2019 | $12,603,000 | -24.5% | 209,769 | +6.1% | 0.01% | -28.6% |
Q2 2019 | $16,686,000 | – | 197,751 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |